Back to RU Rubric Capital Management LP
KNSA
Showing 8 of 20 quarters
Position history for RURubric Capital Management LP's holdings in Kiniksa Pharmaceuticals International, plc
Yes. Rubric Capital Management holds 2,813,469 shares of KNSA (Kiniksa Pharmaceuticals International), worth $209.9M, as of its Q3 2026 13F filing. It reduced the position by 1,186,331 shares (-29.7%) from Q2 2026. Rubric Capital Management has held KNSA since Q2 2022, across 18 quarterly 13F filings. KNSA is 2.0% of Rubric Capital Management's reported 13F portfolio.
Current Value
$209.9M
Current Shares
2.8M
Total Value Change
+$158.1M
Total Shares Change
+194,366
Quarter-by-Quarter History